Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 10, 2023	SC 13G/A	An amendment to the SC 13G filing	0000895345-23-000072.pdf 0000895345-23-000072.rtf View HTML
February 9, 2024	SC 13G/A	An amendment to the SC 13G filing	0000895345-24-000039.pdf 0000895345-24-000039.rtf View HTML
February 13, 2024	SC 13G/A	An amendment to the SC 13G filing	0001104659-24-020210.pdf 0001104659-24-020210.rtf View HTML
April 28, 2023	ARS	An annual report to security holders	0001193125-23-125003.pdf 0001193125-23-125003.rtf View HTML
April 25, 2024	ARS	An annual report to security holders	0001517022-24-000047.pdf 0001517022-24-000047.rtf View HTML
February 10, 2017	5	Annual filing director officer or owner of more than ten percent.	0001562180-17-000613.pdf 0001562180-17-000613.rtf 0001562180-17-000613.xls View HTML
February 14, 2020	5	Annual filing director officer or owner of more than ten percent.	0000899243-20-004675.pdf 0000899243-20-004675.rtf View HTML
March 4, 2015	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-15-001260.pdf 0001564590-15-001260.rtf 0001564590-15-001260.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 14, 2016	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-16-014700.pdf 0001564590-16-014700.rtf 0001564590-16-014700.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
March 6, 2017	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001564590-17-003466.pdf 0001564590-17-003466.rtf 0001564590-17-003466.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax